1. Xu, Xia, Zhang, Xinchao, Xing, Huaixin, Jin, Chunyuan, Zhang, Yingjie. 2019. Importin-4 functions as a driving force in human primary gastric cancer. In Journal of cellular biochemistry, 120, 12638-12646. doi:10.1002/jcb.28530. https://pubmed.ncbi.nlm.nih.gov/30861176/
2. Zhao, Haiyan, Bi, Fangfang, Li, Mengyuan, Diao, Yuhan, Zhang, Chen. 2023. E3 ubiquitin ligase RNF180 impairs IPO4/SOX2 complex stability and inhibits SOX2-mediated malignancy in ovarian cancer. In Cellular signalling, 113, 110961. doi:10.1016/j.cellsig.2023.110961. https://pubmed.ncbi.nlm.nih.gov/37923100/
3. Wu, HaoYuan, Yang, ZhiHao, Chang, ChenXi, Guo, QingGuo, Zhao, Bing. 2024. A novel disulfide death-related genes prognostic signature identifies the role of IPO4 in glioma progression. In Cancer cell international, 24, 168. doi:10.1186/s12935-024-03358-6. https://pubmed.ncbi.nlm.nih.gov/38734657/
4. Xu, Pengpeng, Lin, Wenbo, Liu, Fenglin, Tartakoff, Alan, Tao, Tao. 2017. Competitive regulation of IPO4 transcription by ELK1 and GABP. In Gene, 613, 30-38. doi:10.1016/j.gene.2017.02.030. https://pubmed.ncbi.nlm.nih.gov/28254634/
5. Zhou, Yang, Liu, Fei, Xu, Qinyang, Zhang, Zhigang, Teng, Yincheng. 2020. Inhibiting Importin 4-mediated nuclear import of CEBPD enhances chemosensitivity by repression of PRKDC-driven DNA damage repair in cervical cancer. In Oncogene, 39, 5633-5648. doi:10.1038/s41388-020-1384-3. https://pubmed.ncbi.nlm.nih.gov/32661323/
6. Wang, Jun, Sarkar, Tapasree Roy, Zhou, Ming, Huang, A-Mei, Sterneck, Esta. 2010. CCAAT/enhancer binding protein delta (C/EBPdelta, CEBPD)-mediated nuclear import of FANCD2 by IPO4 augments cellular response to DNA damage. In Proceedings of the National Academy of Sciences of the United States of America, 107, 16131-6. doi:10.1073/pnas.1002603107. https://pubmed.ncbi.nlm.nih.gov/20805509/
智鼠故事 
